Although further studies are required to clarify the role of CD39 and CD73 expression kinetics in T-cell populations, it seems that CD39 downregulation concomitant with CD73 upregulation contributes to COVID-19 patient recovery. This evidence concerns the gene NT5E and COVID-19.